CHANGES IN QUALITY OF LIFE IN PATIENTS UNDERGOING CARDIAC RESYNCHRONISATION THERAPY

Ngọc Dũng Kiều , Quốc Hoàng Nguyễn, Thái Duy Võ , Tri Thức Nguyễn

Main Article Content

Abstract

Background: many studies agree that, using appropriate selection criteria, patients are placed on cardiac resynchronization therapy (CRTs) with heart failure to correct cardiac electro-synchronization and cardiac dyssynchrony. Cardiac mechanics will improve cardiac function, prognosis, and quality of life. However, 30% of patients remain unresponsive to CRT as demonstrated by quality of life. Evaluation of the improvement in the quality of life of patients after CRT is an issue that has not received enough attention. Objective: evaluation of the improvement in quality of life in patients with cardiac resynchronization. Methods: all heart failure patients with indications for CRT placement at Cho Ray hospital from 2015 to the end of 2018, were followed up for at least 3 months after implantation. Research design: A prospective, descriptive, comparative, and interventional study Sample size and sample selection Sample size Convenience sampling, at the end of the study, we selected 38 patients. Result: 38 patients with heart failure have indications for cardiac resynchronization with 50% male gender and 36.8% of patients diagnosed with ischemic cardiomyopathy and 63.2% of patients diagnosed dilated cardiomyopathy. The quality of life scale changed after 1, 2, 3 months was 42.5 ± 12.9, respectively; 67.5 ± 2.9; 81.2 ± 7.8 with p < 0.0001. The physical, mental and overall quality of life scores increased gradually after 1 month and 3 months compared to the time after 7 days. Statistically significant relationship. Conclusion: after 3 months of cardiac resynchronization, recorded: 81.6% of patients responded to CRT; the patient's quality of life increased by 38.6 points (according to the SF36 quality of life scale); walking distance in 6 minutes increases by 30 meters.

Article Details

References

1. Adabag S et al (2011), “Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis”, Journal of the American College of Cardiology, 58(9), pp.935-941
2. Bristow M.R et al (2004), “Cardiac Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure (COMPANION)”, The New England Journal of Medicine, 350(21), pp. 2140-2150
3. Duncker D et al (2016), “First clinical evaluation of an atrial haemodynamic sensor lead for automatic optimization of cardiac resynchronization therapy”, Europace, 18(5), pp.755-761
4. Ellenbogen K.A (2011), “Clinical cardiac pacing, defbrillation, and resynchronization therapy”, Elsevier, 4th editon, pp. 279-297
5. Ellenbogen K.A (2017), “Clinical cardiac pacing, defbrillation, and resynchronization therapy”, Elsevier, 5th editon, pp. 223-243
6. Loring Z et al (2013), “Left Bundle Branch Block Predicts Better Survival in Women Than Men Receiving Cardiac Resynchronization Therapy: Long-Term Follow-Up of 145,000 Patients”, JACC: Heart Failure, 1(3), pp.237
7. Moss A.J et al (2009), “Cardiac-resynchronization therapy for the prevention of heart-failure events”, The New England Journal of Medicine, 361(14), pp.1329-1338
8. Phạm Như Hùng (2012), “Điều trị bệnh nhân suy tim nặng bằng máy tạo nhịp tái đồng bộ tim”. Luận án tiến sĩ0` Y học, Đại học Y Hà Nội, tr.56-99
9. Pires L.A et al (2006), “Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials”, Am Heart J, 151(4), pp.837-843
10. Ponikowski P et al (2016), ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 37(27), pp.2129-2200